RNAC Competitors & Alternatives
Compare Cartesian Therapeutics Inc. with similar stocks in the same industry
Biotechnology
RNAC
Main Stock$10.34
Tradestie Score
56
Market Cap
$266.26M
Revenue Growth
-0.9%
Analyst Upside
+234.3%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ALT
Altimmune, Inc. Common Stock
|
$3.08
|
$341.56M | - | 60 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.96
|
$332.96M | - | 58 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.47
|
$328.62M | - | 59 | Compare |
|
EDIT
Editas Medicine, Inc. Common Stock
|
$3.65
|
$319.22M | - | 50 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$15.53
|
$308.74M | - | 60 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.03
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.30
|
$297.23M | - | 59 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$35.22
|
$293.03M | - | 61 | Compare |
|
OMER
Omeros Corporation
|
$10.34
|
$281.75M | 8.9 | 54 | Compare |
|
DBVT
DBV Technologies S.A.
|
$15.61
|
$275.54M | - | 51 | Compare |
More RNAC Analysis
Data updated: Jul 07, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry